NSYS
NORTECH SYSTEMS INC
Company overview
- Market capitalization
- $31.39M
- Employees
- 685
- Latest publication
- 2026-09-29
About NORTECH SYSTEMS INC
Nortech Systems Incorporated provides engineering design and manufacturing solutions for electromedical devices, electromechanical systems, assemblies, and components in the United States, Mexico, and China. It offers a range of value-added engineering, technical, manufacturing, and support services, including project management, designing, testing, prototyping, manufacturing, supply chain management, and post-market services. The company also manufacturing and engineering services that include complex electromedical and electromechanical product, such as medical devices, wire and cable assemblies, printed circuit board assemblies, complex higher-level assemblies, and other box builds for a range of industries. In addition, it offers engineering and repair services. The company serves original equipment manufacturers in the medical devices and imaging, aerospace and defense, and industrial markets through business development teams and independent manufacturers' representatives. Nortech Systems Incorporated was founded in 1990 and is headquartered in Maple Grove, Minnesota.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 33,540,000USD | 30,316,000USD | 30,313,000USD | 30,482,000USD | 30,675,000USD | 31,407,000USD | 33,891,000USD | 34,215,000USD |
| Cost Of Revenue | 27,837,000USD | 25,614,000USD | 25,247,000USD | 25,457,000USD | 25,838,000USD | 27,572,000USD | 29,274,000USD | 28,767,000USD |
| Gross Profit | 5,703,000USD | 4,702,000USD | 5,066,000USD | 5,025,000USD | 4,837,000USD | 3,835,000USD | 4,617,000USD | 5,448,000USD |
| Research Development | 346,000USD | 310,000USD | 278,000USD | 266,000USD | 302,000USD | 284,000USD | 291,000USD | 318,000USD |
| Selling General Administrative | 3,250,000USD | 3,014,000USD | 2,693,000USD | 2,593,000USD | 2,589,000USD | 2,951,000USD | 2,982,000USD | 3,170,000USD |
| General And Administrative Expenses | 3,250,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 5,080,000USD | 4,655,000USD | 4,165,000USD | 4,080,000USD | 4,095,000USD | 4,302,000USD | 4,273,000USD | 4,293,000USD |
| Operating Income | 623,000USD | 47,000USD | 901,000USD | 945,000USD | 742,000USD | -467,000USD | 344,000USD | 1,155,000USD |
| Total Other Income Expense Net | -197,000USD | -256,000USD | -220,000USD | -273,000USD | -257,000USD | -216,000USD | -165,000USD | -167,000USD |
| Interest Expense | 197,000USD | 256,000USD | 220,000USD | 273,000USD | 257,000USD | 216,000USD | 165,000USD | 167,000USD |
| Income Before Tax | 426,000USD | -209,000USD | 681,000USD | 672,000USD | 485,000USD | -683,000USD | 179,000USD | 988,000USD |
| Income Tax Expense | 110,000USD | -175,000USD | -216,000USD | 818,000USD | 172,000USD | 56,000USD | 22,000USD | 223,000USD |
| Net Income | 316,000USD | -34,000USD | 897,000USD | -146,000USD | 313,000USD | -739,000USD | 157,000USD | 765,000USD |
| Selling And Marketing Expenses | — | 1,331,000USD | 1,194,000USD | 1,221,000USD | 1,204,000USD | 891,000USD | 909,000USD | 805,000USD |
| Net Interest Income | — | -256,000USD | -220,000USD | -273,000USD | -257,000USD | -216,000USD | -165,000USD | -167,000USD |
| Tax Provision | — | -175,000USD | -216,000USD | 818,000USD | 172,000USD | 56,000USD | 22,000USD | 223,000USD |
| Net Income From Continuing Ops | — | -34,000USD | 897,000USD | -146,000USD | 313,000USD | -739,000USD | 157,000USD | 765,000USD |
| Ebit | — | 47,000USD | 901,000USD | 945,000USD | 742,000USD | -467,000USD | 344,000USD | 1,155,000USD |
| Ebitda | — | 350,000USD | 1,203,000USD | 1,248,000USD | 1,073,000USD | -33,000USD | 828,000USD | 1,637,000USD |
| Depreciation And Amortization | — | 303,000USD | 302,000USD | 303,000USD | 331,000USD | 434,000USD | 484,000USD | 482,000USD |
| Reconciled Depreciation | — | 303,000USD | 302,000USD | 308,000USD | 331,000USD | 434,000USD | 484,000USD | 482,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 118,365,000USD | 128,133,000USD | 139,332,000USD | 134,123,000USD | 115,168,000USD | 116,333,000USD | 113,370,000USD | 112,334,749USD |
| Cost Of Revenue | 100,359,000USD | 111,411,000USD | 116,228,000USD | 113,643,000USD | 99,304,000USD | 103,757,000USD | 100,059,000USD | 100,216,948USD |
| Gross Profit | 18,006,000USD | 16,722,000USD | 23,104,000USD | 20,480,000USD | 15,864,000USD | 12,576,000USD | 13,311,000USD | 12,117,801USD |
| Research Development | 1,172,000USD | 1,191,000USD | 1,199,000USD | 1,463,000USD | 483,000USD | — | 0USD | 0USD |
| Selling General Administrative | 10,790,000USD | 11,709,000USD | 12,354,000USD | 11,425,000USD | 10,002,000USD | 9,629,000USD | 8,433,000USD | 8,086,184USD |
| Selling And Marketing Expenses | 4,803,000USD | 3,446,000USD | 3,598,000USD | 3,719,000USD | 2,361,000USD | 2,723,000USD | 3,629,000USD | 4,747,339USD |
| Total Operating Expenses | 16,765,000USD | 16,917,000USD | 17,151,000USD | 16,592,000USD | 13,592,000USD | 12,352,000USD | 12,062,000USD | 12,833,523USD |
| Operating Income | 1,241,000USD | -195,000USD | 5,953,000USD | 3,888,000USD | 2,272,000USD | 224,000USD | 1,249,000USD | -1,268,386USD |
| Interest Expense | 964,000USD | 744,000USD | 487,000USD | 411,000USD | 430,000USD | 1,043,000USD | 757,000USD | 627,555USD |
| Net Interest Income | -964,000USD | -744,000USD | -439,000USD | -411,000USD | -430,000USD | -1,043,000USD | -757,000USD | -627,555USD |
| Income Before Tax | 11,000USD | -939,000USD | 5,466,000USD | 3,477,000USD | 8,013,000USD | -819,000USD | 492,000USD | -2,070,775USD |
| Income Tax Expense | 263,000USD | 356,000USD | -1,408,000USD | 1,467,000USD | 859,000USD | 409,000USD | 326,000USD | 375,000USD |
| Tax Provision | 263,000USD | 356,000USD | 1,445,000USD | 1,467,000USD | 859,000USD | 409,000USD | 326,000USD | 375,000USD |
| Net Income | -252,000USD | -1,295,000USD | 6,874,000USD | 2,010,000USD | 7,154,000USD | -1,228,000USD | 166,000USD | -2,445,775USD |
| Net Income From Continuing Ops | -252,000USD | -1,295,000USD | 2,141,000USD | 2,010,000USD | 7,154,000USD | -1,228,000USD | 166,000USD | -2,445,775USD |
| Ebit | 975,000USD | -195,000USD | 5,953,000USD | 3,888,000USD | 8,443,000USD | 224,000USD | 1,249,000USD | -1,268,386USD |
| Ebitda | 2,263,000USD | 1,543,000USD | 8,003,000USD | 5,806,000USD | 10,393,000USD | 2,445,000USD | 3,438,000USD | 1,232,015USD |
| Depreciation And Amortization | 1,288,000USD | 1,738,000USD | 2,050,000USD | 1,918,000USD | 1,950,000USD | 2,221,000USD | 2,189,000USD | 2,500,401USD |
| Reconciled Depreciation | 1,288,000USD | 1,738,000USD | 2,017,000USD | 1,918,000USD | 1,950,000USD | 2,221,000USD | 2,189,000USD | 2,500,401USD |
| Total Other Income Expense Net | -1,230,000USD | -744,000USD | -487,000USD | -411,000USD | 5,741,000USD | -1,043,000USD | -757,000USD | -174,834USD |
| Net Income Applicable To Common Shares | — | — | — | 2,010,000USD | 7,154,000USD | -1,228,000USD | 166,000USD | -2,445,775USD |
| Interest Income | — | — | — | — | — | 1,043,000USD | 757,000USD | 627,560USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | -174,834USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 80,045,000USD | 76,640,000USD | 71,919,000USD | 74,757,000USD | 74,825,000USD | 73,533,000USD | 72,435,000USD | 76,966,000USD |
| Cash And Equivalents | 1,380,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 64,294,000USD | 60,673,000USD | 56,150,000USD | 59,206,000USD | 58,318,000USD | 57,324,000USD | 55,315,000USD | 60,278,000USD |
| Other Current Assets | 1,279,000USD | 1,315,000USD | 1,618,000USD | 10,744,000USD | 6,244,000USD | 6,180,000USD | 4,094,000USD | 5,065,000USD |
| Total Liabilities | 44,571,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 36,038,000USD | 32,998,000USD | 29,844,000USD | 33,605,000USD | 21,608,000USD | 20,716,000USD | 21,428,000USD | 23,318,000USD |
| Other Non Current Liabilities | 434,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 35,474,000USD | 34,708,000USD | 34,547,000USD | 33,357,000USD | 33,388,000USD | 32,832,000USD | 34,005,000USD | 35,690,000USD |
| Total Equity Including Noncontrolling Interest | 35,474,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 6,848,000USD | — | — | — | — | — | — | — |
| Net Receivables | 19,850,000USD | 33,833,000USD | 32,182,000USD | 34,138,000USD | 32,794,000USD | 29,072,000USD | 28,667,000USD | 31,642,000USD |
| Inventory | 24,512,000USD | 23,561,000USD | 20,695,000USD | 18,425,000USD | 18,628,000USD | 20,910,000USD | 21,638,000USD | 22,332,000USD |
| Property Plant Equipment Net | 11,397,000USD | 11,797,000USD | 12,219,000USD | 12,628,000USD | 13,006,000USD | 13,406,000USD | 14,371,000USD | 13,868,000USD |
| Accounts Payable | 14,949,000USD | 14,645,000USD | 12,809,000USD | 11,678,000USD | 11,931,000USD | 10,062,000USD | 11,582,000USD | 12,315,000USD |
| Short Term Debt | 1,246,000USD | 9,486,000USD | 10,212,000USD | 13,588,000USD | 1,466,000USD | 1,871,000USD | 1,318,000USD | 1,349,000USD |
| Common Stock | 29,000USD | 28,000USD | 28,000USD | 28,000USD | 28,000USD | 28,000USD | 28,000USD | 28,000USD |
| Retained Earnings | 17,405,000USD | 17,089,000USD | 17,123,000USD | 16,226,000USD | 16,372,000USD | 16,059,000USD | 17,375,000USD | 18,853,000USD |
| Accumulated Other Comprehensive Income | -619,000USD | -640,000USD | -709,000USD | -867,999USD | -847,000USD | -971,000USD | -977,000USD | -667,000USD |
| Intangible Assets | — | 151,000USD | 156,000USD | 160,000USD | 165,000USD | 169,000USD | 174,000USD | 179,000USD |
| Total Liab | — | 41,932,000USD | 37,372,000USD | 41,400,000USD | 41,437,000USD | 40,701,000USD | 38,430,000USD | 41,276,000USD |
| Other Current Liab | — | 4,195,000USD | 6,086,000USD | 8,339,000USD | 3,035,000USD | 3,755,000USD | 3,388,000USD | 4,391,000USD |
| Capital Stock | — | 278,000USD | 278,000USD | 278,000USD | 278,000USD | 278,000USD | 278,000USD | 278,000USD |
| Cash | — | 1,964,000USD | 1,655,000USD | 1,271,000USD | 652,000USD | 1,162,000USD | 916,000USD | 1,239,000USD |
| Cash And Short Term Investments | — | 1,964,000USD | 1,655,000USD | 1,271,000USD | 652,000USD | 1,162,000USD | 916,000USD | 1,239,000USD |
| Current Deferred Revenue | — | 4,672,000USD | 5,386,000USD | 4,716,000USD | 5,176,000USD | 5,028,000USD | 5,140,000USD | 5,263,000USD |
| Net Debt | — | 16,028,000USD | 14,053,000USD | 19,825,000USD | 20,355,000USD | 20,407,000USD | 17,120,000USD | 17,647,000USD |
| Short Long Term Debt | — | 7,918,000USD | 7,000,000USD | 12,030,000USD | — | 563,000USD | — | — |
| Short Long Term Debt Total | — | 17,992,000USD | 15,708,000USD | 21,096,000USD | 21,007,000USD | 21,569,000USD | 18,036,000USD | 18,886,000USD |
| Long Term Debt | — | 1,743,000USD | — | — | 11,615,000USD | 11,955,000USD | 8,634,000USD | 9,508,000USD |
| Property Plant Equipment Gross | — | 11,797,000USD | 37,067,000USD | 12,628,000USD | 13,006,000USD | 13,406,000USD | 41,644,000USD | 13,868,000USD |
| Common Stock Shares Outstanding | — | 2,786,134shares | 2,776,680shares | 2,785,541shares | 2,954,765shares | 2,760,929shares | 2,756,943shares | 2,760,438shares |
| Non Current Assets Total | — | 15,967,000USD | 15,769,000USD | 15,551,000USD | 16,507,000USD | 16,209,000USD | 17,120,000USD | 16,688,000USD |
| Non Current Liabilities Total | — | 8,934,000USD | 7,527,999USD | 7,795,000USD | 19,829,000USD | 19,985,000USD | 17,002,000USD | 17,958,000USD |
| Non Current Liabilities Other | — | 428,000USD | 426,000USD | 287,000USD | 288,000USD | 287,000USD | 284,000USD | 421,000USD |
| Non Currrent Assets Other | — | 266,000USD | — | 2,763,000USD | 61,000USD | 59,000USD | — | — |
| Net Working Capital | — | 27,675,000USD | 26,306,000USD | 25,601,000USD | 36,710,000USD | 36,608,000USD | 33,887,000USD | 36,960,000USD |
| Unclassified Non Current Assets | — | 3,753,000USD | 3,394,000USD | — | 3,275,000USD | 2,575,000USD | 2,575,000USD | 2,641,000USD |
| Unclassified Current Liabilities | — | -7,918,000USD | -11,649,000USD | -16,746,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | — | 6,763,000USD | 7,101,999USD | 7,508,000USD | 7,926,000USD | 7,743,000USD | 8,084,000USD | 8,029,000USD |
| Unclassified Equity | — | 17,953,000USD | 17,827,000USD | 17,692,999USD | 17,557,000USD | 17,438,000USD | 17,301,000USD | 17,198,000USD |
| Unclassified Current Assets | — | — | — | -5,372,000USD | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 71,919,000USD | 72,435,000USD | 75,127,000USD | 69,540,000USD | 67,091,000USD | 57,634,000USD | 61,410,000USD | 59,960,000USD |
| Intangible Assets | 156,000USD | 174,000USD | 263,000USD | 422,000USD | 501,000USD | 1,173,000USD | 1,343,000USD | 1,523,000USD |
| Other Current Assets | 1,618,000USD | 4,094,000USD | 2,413,000USD | 2,788,000USD | 3,242,000USD | 5,244,000USD | 2,437,000USD | 1,381,000USD |
| Total Liab | 37,372,000USD | 38,430,000USD | 39,783,000USD | 41,460,000USD | 40,980,000USD | 38,916,000USD | 41,434,000USD | 38,870,000USD |
| Total Stockholder Equity | 34,547,000USD | 34,005,000USD | 35,344,000USD | 28,080,000USD | 26,111,000USD | 18,718,000USD | 19,976,000USD | 21,090,000USD |
| Other Current Liab | 3,043,000USD | 3,388,000USD | 9,269,000USD | 6,546,000USD | 7,952,000USD | 5,745,000USD | 6,359,000USD | 6,750,000USD |
| Common Stock | 28,000USD | 28,000USD | 27,000USD | 27,000USD | 27,000USD | 27,000USD | 27,000USD | 27,000USD |
| Capital Stock | 278,000USD | 278,000USD | 277,000USD | 277,000USD | 277,000USD | 277,000USD | 277,000USD | 277,000USD |
| Retained Earnings | 17,123,000USD | 17,375,000USD | 18,670,000USD | 11,826,000USD | 9,816,000USD | 2,662,000USD | 4,208,000USD | 5,436,000USD |
| Cash | 1,655,000USD | 916,000USD | 960,000USD | 1,027,000USD | 643,000USD | 352,000USD | 351,000USD | 480,000USD |
| Cash And Short Term Investments | 1,655,000USD | 916,000USD | 960,000USD | 1,027,000USD | 643,000USD | 352,000USD | 351,000USD | 480,000USD |
| Total Current Assets | 56,150,000USD | 55,315,000USD | 58,793,000USD | 54,860,000USD | 51,774,000USD | 41,037,000USD | 43,284,000USD | 45,856,000USD |
| Total Current Liabilities | 29,844,000USD | 21,428,000USD | 26,582,000USD | 26,398,000USD | 22,306,000USD | 19,536,000USD | 22,232,000USD | 24,892,000USD |
| Current Deferred Revenue | 5,386,000USD | 5,140,000USD | 4,068,000USD | 3,515,000USD | — | — | — | -1,117,000USD |
| Net Debt | 14,053,000USD | 17,120,000USD | 13,216,000USD | 15,485,000USD | 19,571,000USD | 21,434,000USD | 20,592,000USD | 13,498,000USD |
| Short Term Debt | 8,606,000USD | 1,318,000USD | 1,389,000USD | 1,545,000USD | 1,644,000USD | 2,552,000USD | 1,859,000USD | 1,117,000USD |
| Short Long Term Debt | 7,000,000USD | — | — | — | — | 1,204,000USD | 444,000USD | 780,000USD |
| Short Long Term Debt Total | 15,708,000USD | 18,036,000USD | 14,176,000USD | 16,512,000USD | 20,214,000USD | 21,786,000USD | 20,943,000USD | 14,956,000USD |
| Net Receivables | 32,182,000USD | 28,667,000USD | 33,760,000USD | 28,607,000USD | 28,455,000USD | 21,524,000USD | 26,217,000USD | 26,524,000USD |
| Inventory | 20,695,000USD | 21,638,000USD | 21,660,000USD | 22,438,000USD | 19,434,000USD | 13,917,000USD | 14,279,000USD | 17,004,000USD |
| Accounts Payable | 12,809,000USD | 11,582,000USD | 15,924,000USD | 14,792,000USD | 12,710,000USD | 11,239,000USD | 14,014,000USD | 18,142,000USD |
| Property Plant Equipment Net | 12,219,000USD | 14,371,000USD | 13,430,000USD | 14,258,000USD | 14,816,000USD | 15,424,000USD | 14,408,000USD | 10,206,000USD |
| Property Plant Equipment Gross | 37,067,000USD | 41,644,000USD | 40,368,000USD | 14,258,000USD | 39,040,000USD | 6,426,000USD | 14,408,000USD | 10,178,000USD |
| Accumulated Other Comprehensive Income | -709,000USD | -977,000USD | -532,000USD | -370,000USD | 56,000USD | -37,000USD | -257,000USD | -233,000USD |
| Common Stock Shares Outstanding | 2,776,680shares | 2,758,691shares | 2,885,879shares | 2,891,285shares | 2,821,523shares | 2,657,738shares | 2,665,165shares | 2,699,614shares |
| Non Current Assets Total | 15,769,000USD | 17,120,000USD | 16,334,000USD | 14,680,000USD | 15,317,000USD | 16,597,000USD | 18,126,000USD | 14,104,000USD |
| Non Current Liabilities Total | 7,527,999USD | 17,002,000USD | 13,201,000USD | 15,062,000USD | 18,674,000USD | 19,380,000USD | 19,202,000USD | 13,978,000USD |
| Non Current Liabilities Other | 426,000USD | 284,000USD | 414,000USD | 95,000USD | 104,000USD | 146,000USD | 5,935,000USD | 139,000USD |
| Net Working Capital | 26,306,000USD | 33,887,000USD | 32,211,000USD | 28,462,000USD | 29,468,000USD | 21,501,000USD | 21,052,000USD | 20,964,000USD |
| Unclassified Non Current Assets | 3,394,000USD | 2,575,000USD | 2,640,999USD | — | — | -8,998,000USD | — | — |
| Unclassified Current Liabilities | -7,000,000USD | — | -4,068,000USD | — | — | -1,204,000USD | — | -1,897,000USD |
| Unclassified Non Current Liabilities | 7,101,999USD | 8,084,000USD | 6,972,000USD | 8,019,000USD | 9,507,000USD | 9,895,000USD | — | — |
| Unclassified Equity | 17,827,000USD | 17,301,000USD | 16,902,000USD | 16,320,000USD | 15,935,000USD | 15,789,000USD | 15,721,000USD | 15,583,000USD |
| Long Term Debt | — | 8,634,000USD | 5,815,000USD | 6,853,000USD | 8,959,000USD | 9,193,000USD | 13,267,000USD | 12,888,000USD |
| Other Assets | — | — | 1USD | 1,000USD | — | 8,998,000USD | — | 28,000USD |
| Non Currrent Assets Other | — | — | -1USD | -14,680,000USD | -15,317,000USD | -16,597,000USD | -18,126,000USD | 28,000USD |
| Other Liab | — | — | — | 95,000USD | 104,000USD | 146,000USD | 118,000USD | 139,000USD |
| Net Tangible Assets | — | — | — | 27,408,000USD | 25,360,000USD | 17,295,000USD | 16,008,000USD | 16,942,000USD |
| Good Will | — | — | — | — | — | 0USD | 2,375,000USD | 2,375,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -34,000USD | 897,000USD | -146,000USD | 313,000USD | -1,316,000USD | -1,478,000USD | -739,000USD | 157,000USD |
| Depreciation | 303,000USD | 289,000USD | 308,000USD | 331,000USD | 347,000USD | 338,000USD | 434,000USD | 484,000USD |
| Stock Based Compensation | 126,000USD | 134,000USD | 134,000USD | 117,000USD | 118,000USD | 127,000USD | 128,000USD | 126,000USD |
| Other Non Cash Items | -213,000USD | 43,000USD | -25,000USD | -605,000USD | 266,000USD | -48,000USD | 165,000USD | -40,000USD |
| Change To Account Receivables | -1,648,000USD | 2,067,000USD | -1,377,000USD | -3,608,000USD | -426,000USD | 2,611,000USD | 936,000USD | -2,288,000USD |
| Change To Inventory | -2,610,000USD | -2,338,000USD | 109,000USD | 2,227,000USD | 487,000USD | 522,000USD | 366,000USD | 112,000USD |
| Change In Working Capital | -1,384,000USD | 4,614,000USD | -874,000USD | 1,000USD | -2,345,000USD | 1,854,000USD | -1,573,000USD | -5,013,000USD |
| Total Cash From Operating Activities | -1,561,000USD | 5,608,000USD | -92,000USD | 157,000USD | -2,930,000USD | 793,000USD | -1,585,000USD | -4,286,000USD |
| Capital Expenditures | -228,000USD | -661,000USD | -150,000USD | -99,000USD | -268,000USD | -290,000USD | -40,000USD | -276,000USD |
| Free Cash Flow | -1,789,000USD | 4,947,000USD | -242,000USD | 58,000USD | -3,198,000USD | 503,000USD | -1,545,000USD | -4,562,000USD |
| Total Cashflows From Investing Activities | -228,000USD | -144,000USD | 345,000USD | -90,000USD | -268,000USD | -292,000USD | 40,000USD | -276,000USD |
| Net Borrowings | 2,626,000USD | -5,085,000USD | 360,000USD | -592,000USD | 3,427,000USD | -770,000USD | 1,285,000USD | — |
| Total Cash From Financing Activities | 2,336,000USD | -5,085,000USD | 360,000USD | -588,000USD | 3,446,000USD | -796,000USD | 1,218,000USD | 2,069,000USD |
| Change In Cash | 553,000USD | 384,000USD | 619,000USD | -510,000USD | 246,000USD | -323,000USD | -303,000USD | -2,486,000USD |
| Begin Period Cash Flow | 1,655,000USD | 1,271,000USD | 652,000USD | 1,162,000USD | 916,000USD | 1,239,000USD | 1,542,000USD | 4,028,000USD |
| End Period Cash Flow | 2,208,000USD | 1,655,000USD | 1,271,000USD | 652,000USD | 1,162,000USD | 916,000USD | 1,239,000USD | 1,542,000USD |
| Other Cashflows From Financing Activities | 2,336,000USD | -5,085,000USD | 360,000USD | 4,000USD | 19,000USD | 7,000USD | -67,000USD | 31,000USD |
| Unclassified Financing Cash Flow | -2,626,000USD | 5,085,000USD | — | — | — | — | — | 2,038,000USD |
| Sale Purchase Of Stock | — | 0USD | — | — | — | -33,000USD | — | — |
| Other Cashflows From Investing Activities | — | 517,000USD | -22,000USD | 9,000USD | — | -2,000USD | -980,000USD | — |
| Investments | — | — | 345,000USD | -90,000USD | -268,000USD | -292,000USD | 40,000USD | -276,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | 1,020,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -252,000USD | -1,295,000USD | 6,874,000USD | 2,010,000USD | 7,154,000USD | -1,546,000USD | -1,228,000USD | 166,000USD |
| Depreciation | 1,270,000USD | 1,738,000USD | 2,050,000USD | 1,918,000USD | 1,950,000USD | 2,193,000USD | 2,221,000USD | 2,189,000USD |
| Stock Based Compensation | 503,000USD | 461,000USD | 423,000USD | 334,000USD | 259,000USD | 68,000USD | 261,000USD | 126,000USD |
| Other Non Cash Items | 384,000USD | 95,000USD | 50,000USD | -230,000USD | -4,527,000USD | -658,000USD | 519,000USD | 281,000USD |
| Change To Account Receivables | -3,344,000USD | 4,761,000USD | -6,128,000USD | 188,000USD | -1,665,000USD | 4,104,000USD | 586,000USD | -2,746,000USD |
| Change To Inventory | 485,000USD | 280,000USD | 716,000USD | -2,985,000USD | -4,613,000USD | -216,000USD | 2,344,000USD | -3,875,000USD |
| Change In Working Capital | 1,396,000USD | -3,237,000USD | -5,266,000USD | 1,370,000USD | -9,376,000USD | 1,306,000USD | -796,000USD | -319,000USD |
| Total Cash From Operating Activities | 2,743,000USD | -2,250,000USD | 1,769,000USD | 5,402,000USD | -4,540,000USD | 1,363,000USD | 997,000USD | 2,444,000USD |
| Capital Expenditures | -661,000USD | -1,270,000USD | -1,284,000USD | -2,441,000USD | -1,292,000USD | -519,000USD | -758,000USD | -1,404,000USD |
| Free Cash Flow | 2,082,000USD | -3,520,000USD | 485,000USD | 2,961,000USD | -5,832,000USD | 844,000USD | 239,000USD | 1,040,000USD |
| Total Cashflows From Investing Activities | -157,000USD | -1,263,000USD | -1,284,000USD | -2,426,000USD | -730,000USD | 5,500,000USD | -758,000USD | -1,390,000USD |
| Net Borrowings | -1,890,000USD | 2,827,000USD | -1,440,000USD | -2,718,000USD | 3,896,000USD | -3,959,000USD | -402,000USD | -613,000USD |
| Total Cash From Financing Activities | -1,867,000USD | 2,765,000USD | -1,281,000USD | -2,667,000USD | 3,931,000USD | -3,959,000USD | -525,000USD | -889,000USD |
| Sale Purchase Of Stock | 0USD | -100,000USD | 0USD | — | — | 0USD | -130,000USD | -276,000USD |
| Change In Cash | 739,000USD | -759,000USD | -806,000USD | 256,000USD | -1,339,000USD | 2,904,000USD | -287,000USD | 168,000USD |
| Begin Period Cash Flow | 916,000USD | 1,675,000USD | 2,481,000USD | 2,225,000USD | 3,564,000USD | 660,000USD | 947,000USD | 779,000USD |
| End Period Cash Flow | 1,655,000USD | 916,000USD | 1,675,000USD | 2,481,000USD | 2,225,000USD | 3,564,000USD | 660,000USD | 947,000USD |
| Other Cashflows From Investing Activities | 504,000USD | 7,000USD | — | -56,000USD | 562,000USD | 5,985,000USD | -39,000USD | 14,000USD |
| Other Cashflows From Financing Activities | -1,867,000USD | 38,000USD | 159,000USD | 51,000USD | 35,000USD | 5,500,000USD | 7,000USD | 761,000USD |
| Unclassified Financing Cash Flow | 1,890,000USD | — | — | — | — | -5,500,000USD | — | — |
| Investments | — | -1,263,000USD | -1,832,000USD | -2,426,000USD | -730,000USD | 5,500,000USD | -758,000USD | -1,390,000USD |
| Unclassified Investing Cash Flow | — | 1,263,000USD | 1,832,000USD | 2,497,000USD | — | -5,466,000USD | — | 1,390,000USD |
| Unclassified Operating Cash Flow | — | — | -2,362,000USD | — | — | — | — | — |
| Change To Liabilities | — | — | — | 2,216,000USD | 1,471,000USD | -2,950,000USD | -2,711,000USD | 6,641,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 2,904,000USD | -287,000USD | 168,000USD |
| Dividends Paid | — | — | — | — | — | — | -7,000USD | — |
| Exchange Rate Changes | — | — | — | — | — | — | -1,000USD | 3,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | China | 5,510,000 | USD | 0001493152-26-022752 |
| Q1 2026Quarterly · 2026-03-31 | Geography | MX | 7,342,000 | USD | 0001493152-26-022752 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 17,464,000 | USD | 0001493152-26-022752 |
| Q1 2026Quarterly · 2026-03-31 | Product | Aerospace And Defense | 4,647,000 | USD | 0001493152-26-022752 |
| Q1 2026Quarterly · 2026-03-31 | Product | Industrial | 6,882,000 | USD | 0001493152-26-022752 |
| Q1 2026Quarterly · 2026-03-31 | Product | Medical Device | 8,911,000 | USD | 0001493152-26-022752 |
| Q1 2026Quarterly · 2026-03-31 | Product | Medical Imaging | 9,876,000 | USD | 0001493152-26-022752 |
| Q4 2025Quarterly · 2025-12-31 | Product | Aerospace And Defense | 3,729,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Industrial | 7,267,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Medical Device | 7,959,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Medical Imaging | 11,358,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | China | 1,328,000 | USD | 0001493152-26-022752 |
| FY 2025Yearly · 2025-12-31 | Geography | MX | 2,015,000 | USD | 0001493152-26-022752 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 8,876,000 | USD | 0001493152-26-022752 |
| FY 2025Yearly · 2025-12-31 | Product | Aerospace And Defense | 15,496,000 | USD | 0001493152-26-012913 |
| FY 2025Yearly · 2025-12-31 | Product | Industrial | 30,940,000 | USD | 0001493152-26-012913 |
| FY 2025Yearly · 2025-12-31 | Product | Medical Device | 31,930,000 | USD | 0001493152-26-012913 |
| FY 2025Yearly · 2025-12-31 | Product | Medical Imaging | 39,999,000 | USD | 0001493152-26-012913 |
| Q3 2025Quarterly · 2025-09-30 | Geography | China | 5,233,000 | USD | 0001493152-25-022124 |
| Q3 2025Quarterly · 2025-09-30 | Geography | MX | 7,079,000 | USD | 0001493152-25-022124 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 18,170,000 | USD | 0001493152-25-022124 |
| Q3 2025Quarterly · 2025-09-30 | Product | Aerospace And Defense | 3,530,000 | USD | 0001493152-25-022124 |
| Q3 2025Quarterly · 2025-09-30 | Product | Industrial | 8,212,000 | USD | 0001493152-25-022124 |
| Q3 2025Quarterly · 2025-09-30 | Product | Medical Device | 8,351,000 | USD | 0001493152-25-022124 |
| Q3 2025Quarterly · 2025-09-30 | Product | Medical Imaging | 10,389,000 | USD | 0001493152-25-022124 |
| Q2 2025Quarterly · 2025-06-30 | Geography | China | 4,775,000 | USD | 0001641172-25-022507 |
| Q2 2025Quarterly · 2025-06-30 | Geography | MX | 7,895,000 | USD | 0001641172-25-022507 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 18,005,000 | USD | 0001641172-25-022507 |
| Q2 2025Quarterly · 2025-06-30 | Product | Aerospace And Defense | 4,945,000 | USD | 0001641172-25-022507 |
| Q2 2025Quarterly · 2025-06-30 | Product | Industrial | 8,516,000 | USD | 0001641172-25-022507 |
| Q2 2025Quarterly · 2025-06-30 | Product | Medical Device | 7,550,000 | USD | 0001641172-25-022507 |
| Q2 2025Quarterly · 2025-06-30 | Product | Medical Imaging | 9,664,000 | USD | 0001641172-25-022507 |
| Q1 2025Quarterly · 2025-03-31 | Geography | China | 4,005,000 | USD | 0001493152-26-022752 |
| Q1 2025Quarterly · 2025-03-31 | Geography | MX | 6,580,000 | USD | 0001493152-26-022752 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 16,310,000 | USD | 0001493152-26-022752 |
| Q1 2025Quarterly · 2025-03-31 | Product | Aerospace And Defense | 3,292,000 | USD | 0001493152-26-022752 |
| Q1 2025Quarterly · 2025-03-31 | Product | Industrial | 6,945,000 | USD | 0001493152-26-022752 |
| Q1 2025Quarterly · 2025-03-31 | Product | Medical Device | 8,070,000 | USD | 0001493152-26-022752 |
| Q1 2025Quarterly · 2025-03-31 | Product | Medical Imaging | 8,588,000 | USD | 0001493152-26-022752 |
| Q4 2024Quarterly · 2024-12-31 | Product | Aerospace And Defense | 3,067,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Industrial | 9,625,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Medical Device | 5,719,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Medical Imaging | 10,209,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | China | 1,497,000 | USD | 0001493152-25-022124 |
| FY 2024Yearly · 2024-12-31 | Geography | MX | 2,445,000 | USD | 0001493152-25-022124 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 10,429,000 | USD | 0001493152-25-022124 |
| FY 2024Yearly · 2024-12-31 | Product | Aerospace And Defense | 20,488,000 | USD | 0001493152-26-012913 |
| FY 2024Yearly · 2024-12-31 | Product | Industrial | 35,517,000 | USD | 0001493152-26-012913 |
| FY 2024Yearly · 2024-12-31 | Product | Medical Device | 34,636,000 | USD | 0001493152-26-012913 |
| FY 2024Yearly · 2024-12-31 | Product | Medical Imaging | 37,492,000 | USD | 0001493152-26-012913 |
| Q3 2024Quarterly · 2024-09-30 | Geography | China | 3,496,000 | USD | 0001493152-25-022124 |
| Q3 2024Quarterly · 2024-09-30 | Geography | MX | 7,207,000 | USD | 0001493152-25-022124 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 20,704,000 | USD | 0001493152-25-022124 |
| Q3 2024Quarterly · 2024-09-30 | Product | Aerospace And Defense | 4,926,000 | USD | 0001493152-25-022124 |
| Q3 2024Quarterly · 2024-09-30 | Product | Industrial | 8,434,000 | USD | 0001493152-25-022124 |
| Q3 2024Quarterly · 2024-09-30 | Product | Medical Device | 8,490,000 | USD | 0001493152-25-022124 |
| Q3 2024Quarterly · 2024-09-30 | Product | Medical Imaging | 9,557,000 | USD | 0001493152-25-022124 |
| Q2 2024Quarterly · 2024-06-30 | Geography | China | 3,840,000 | USD | 0001641172-25-022507 |
| Q2 2024Quarterly · 2024-06-30 | Geography | MX | 7,571,000 | USD | 0001641172-25-022507 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 22,480,000 | USD | 0001641172-25-022507 |
| Q2 2024Quarterly · 2024-06-30 | Product | Aerospace And Defense | 6,635,000 | USD | 0001641172-25-022507 |
| Q2 2024Quarterly · 2024-06-30 | Product | Industrial | 9,385,000 | USD | 0001641172-25-022507 |
| Q2 2024Quarterly · 2024-06-30 | Product | Medical Device | 9,689,000 | USD | 0001641172-25-022507 |
| Q2 2024Quarterly · 2024-06-30 | Product | Medical Imaging | 8,182,000 | USD | 0001641172-25-022507 |
| Q1 2024Quarterly · 2024-03-31 | Geography | China | 3,900,000 | USD | 0001641172-25-010251 |
| Q1 2024Quarterly · 2024-03-31 | Geography | MX | 6,786,000 | USD | 0001641172-25-010251 |
| Q1 2024Quarterly · 2024-03-31 | Geography | United States | 23,529,000 | USD | 0001641172-25-010251 |
| FY 2023Yearly · 2023-12-31 | Geography | China | 1,139,000 | USD | 0001641172-25-001473 |
| FY 2023Yearly · 2023-12-31 | Geography | MX | 2,870,000 | USD | 0001641172-25-001473 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 9,421,000 | USD | 0001641172-25-001473 |
| FY 2023Yearly · 2023-12-31 | Product | Aerospace And Defense | 20,553,000 | USD | 0001641172-25-001473 |
| FY 2023Yearly · 2023-12-31 | Product | Industrial | 40,113,000 | USD | 0001641172-25-001473 |
| FY 2023Yearly · 2023-12-31 | Product | Medical Device | 38,758,000 | USD | 0001641172-25-001473 |
| FY 2023Yearly · 2023-12-31 | Product | Medical Imaging | 39,908,000 | USD | 0001641172-25-001473 |
| FY 2022Yearly · 2022-12-31 | Product | Aerospace And Defense | 19,479,000 | USD | 0001437749-24-008690 |
| FY 2022Yearly · 2022-12-31 | Product | Industrial | 38,737,000 | USD | 0001437749-24-008690 |
| FY 2022Yearly · 2022-12-31 | Product | Medical | 75,907,000 | USD | 0001437749-24-008690 |
| FY 2021Yearly · 2021-12-31 | Product | Aerospace And Defense | 16,639,000 | USD | 0001437749-23-007041 |
| FY 2021Yearly · 2021-12-31 | Product | Industrial | 35,482,000 | USD | 0001437749-23-007041 |
| FY 2021Yearly · 2021-12-31 | Product | Medical | 63,047,000 | USD | 0001437749-23-007041 |
| FY 2020Yearly · 2020-12-31 | Product | Aerospace And Defense | 20,624,000 | USD | 0001437749-22-006550 |
| FY 2020Yearly · 2020-12-31 | Product | Industrial | 28,384,000 | USD | 0001437749-22-006550 |
| FY 2020Yearly · 2020-12-31 | Product | Medical | 55,098,000 | USD | 0001437749-22-006550 |
| FY 2019Yearly · 2019-12-31 | Product | Aerospace And Defense | 18,207,000 | USD | 0001437749-21-006916 |
| FY 2019Yearly · 2019-12-31 | Product | Industrial | 35,514,000 | USD | 0001437749-21-006916 |
| FY 2019Yearly · 2019-12-31 | Product | Medical | 62,612,000 | USD | 0001437749-21-006916 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Aerospace And Defense | 4,245,000 | USD | 0001104659-19-029747 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Industrial | 8,981,000 | USD | 0001104659-19-029747 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Medical | 14,939,000 | USD | 0001104659-19-029747 |
| FY 2018Yearly · 2018-12-31 | Product | Aerospace And Defense | 18,314,000 | USD | 0001437749-20-005686 |
| FY 2018Yearly · 2018-12-31 | Product | Industrial | 45,082,000 | USD | 0001437749-20-005686 |
| FY 2018Yearly · 2018-12-31 | Product | Medical | 49,974,000 | USD | 0001437749-20-005686 |
| Q4 2018Quarterly · 2018-12-31 | Segment | Aerospace And Defense | 4,995,000 | USD | Legacy provider |
| Q4 2018Quarterly · 2018-12-31 | Segment | Industrial | 15,916,000 | USD | Legacy provider |
| Q4 2018Quarterly · 2018-12-31 | Segment | Medical | 7,916,000 | USD | Legacy provider |
| FY 2018Yearly · 2018-12-31 | Segment | Aerospace And Defense | 18,314,000 | USD | 0001104659-19-018979 |
| FY 2018Yearly · 2018-12-31 | Segment | Industrial | 49,974,000 | USD | 0001104659-19-018979 |
| FY 2018Yearly · 2018-12-31 | Segment | Medical | 45,082,000 | USD | 0001104659-19-018979 |
| Q3 2018Quarterly · 2018-09-30 | Segment | Aerospace And Defense | 4,184,000 | USD | 0001104659-18-068455 |
| Q3 2018Quarterly · 2018-09-30 | Segment | Industrial | 11,094,000 | USD | 0001104659-18-068455 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.